IL6 and COVID-19: This evidence underpins the current hypothesis that NOX is an essential regulator in COVID-19 pathogenesis, and that blocking the expression of NOX might hinder the production of ATII-induced ROS and IL-6, minimising inflammation and tissue injury (Fig. 2).